Microbix Biosystems, Inc. (MBXBF)
0.2187
0.00 (0.00%)
USD |
OTCM |
Jun 18, 16:00
Microbix Biosystems SG&A Expense (Quarterly) : 1.400M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.400M |
| December 31, 2025 | 1.285M |
| September 30, 2025 | 1.382M |
| June 30, 2025 | 1.267M |
| March 31, 2025 | 1.412M |
| December 31, 2024 | 1.298M |
| September 30, 2024 | 1.307M |
| June 30, 2024 | 1.210M |
| March 31, 2024 | 1.218M |
| December 31, 2023 | 2.059M |
| September 30, 2023 | 1.108M |
| June 30, 2023 | 1.567M |
| March 31, 2023 | 1.110M |
| December 31, 2022 | 1.179M |
| September 30, 2022 | 1.098M |
| June 30, 2022 | 0.8883M |
| March 31, 2022 | 1.023M |
| December 31, 2021 | 1.030M |
| September 30, 2021 | 0.8101M |
| June 30, 2021 | 0.9724M |
| March 31, 2021 | 0.882M |
| December 31, 2020 | 0.7555M |
| September 30, 2020 | 0.5512M |
| June 30, 2020 | 0.787M |
| March 31, 2020 | 0.6189M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.6685M |
| September 30, 2019 | 0.7615M |
| June 30, 2019 | 0.8774M |
| March 31, 2019 | 0.8754M |
| December 31, 2018 | 0.6734M |
| September 30, 2018 | 0.8746M |
| June 30, 2018 | 0.7988M |
| March 31, 2018 | 0.826M |
| December 31, 2017 | 0.7484M |
| September 30, 2017 | 1.117M |
| June 30, 2017 | 0.8643M |
| March 31, 2017 | 0.6882M |
| December 31, 2016 | 0.6894M |
| September 30, 2016 | 0.881M |
| June 30, 2016 | 0.7514M |
| March 31, 2016 | 0.6694M |
| December 31, 2015 | 0.4247M |
| September 30, 2015 | 0.4541M |
| June 30, 2015 | 0.7658M |
| March 31, 2015 | 0.8976M |
| December 31, 2014 | 0.723M |
| September 30, 2014 | 0.5749M |
| June 30, 2014 | 0.5239M |
| March 31, 2014 | 0.5576M |
| December 31, 2013 | 0.6591M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 22.03M |
| enGene Therapeutics, Inc. | 0.00 |
| Medicus Pharma Ltd. | 4.296M |
| Xenon Pharmaceuticals, Inc. | 23.82M |
| Psyence Biomedical Ltd. | 0.2659M |